GDUFA IV: More ANDA Postmarket Commitments Coming?

Would more generic drug PMRs and PMCs create resource issues for the FDA? (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from United States